MA40332A - Réduction des niveaux de cétone alpha, beta-insaturée dans des compositions de dérivés de morphinane - Google Patents
Réduction des niveaux de cétone alpha, beta-insaturée dans des compositions de dérivés de morphinaneInfo
- Publication number
- MA40332A MA40332A MA040332A MA40332A MA40332A MA 40332 A MA40332 A MA 40332A MA 040332 A MA040332 A MA 040332A MA 40332 A MA40332 A MA 40332A MA 40332 A MA40332 A MA 40332A
- Authority
- MA
- Morocco
- Prior art keywords
- beta
- alpha
- reduction
- unsaturated ketone
- ketone levels
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D489/00—Heterocyclic compounds containing 4aH-8, 9 c- Iminoethano-phenanthro [4, 5-b, c, d] furan ring systems, e.g. derivatives of [4, 5-epoxy]-morphinan of the formula:
- C07D489/06—Heterocyclic compounds containing 4aH-8, 9 c- Iminoethano-phenanthro [4, 5-b, c, d] furan ring systems, e.g. derivatives of [4, 5-epoxy]-morphinan of the formula: with a hetero atom directly attached in position 14
- C07D489/08—Oxygen atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/485—Morphinan derivatives, e.g. morphine, codeine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
- C07B2200/00—Indexing scheme relating to specific properties of organic compounds
- C07B2200/13—Crystalline forms, e.g. polymorphs
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201462022514P | 2014-07-09 | 2014-07-09 |
Publications (1)
Publication Number | Publication Date |
---|---|
MA40332A true MA40332A (fr) | 2021-04-28 |
Family
ID=53761450
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MA040332A MA40332A (fr) | 2014-07-09 | 2015-07-08 | Réduction des niveaux de cétone alpha, beta-insaturée dans des compositions de dérivés de morphinane |
Country Status (5)
Country | Link |
---|---|
US (2) | US20170342084A1 (fr) |
EP (1) | EP3166948A1 (fr) |
CA (1) | CA2954600A1 (fr) |
MA (1) | MA40332A (fr) |
WO (1) | WO2016005923A1 (fr) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20200163931A1 (en) * | 2016-10-12 | 2020-05-28 | Columbia Care Llc | Oral composition of extracted cannabinoids and methods of use thereof |
EP3495371A1 (fr) | 2017-12-05 | 2019-06-12 | Siegfried AG | Synthèse de noroxymorphone |
AU2021368196A1 (en) | 2020-11-02 | 2023-06-22 | Rhodes Technologies | Process for purifying noroxymorphone |
Family Cites Families (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
TW201509943A (zh) * | 2004-03-30 | 2015-03-16 | Euro Celtique Sa | 含有小於25ppm14-羥可待因酮之羥可酮鹽酸鹽之組成物、醫藥劑型、延遲釋出口服劑型及醫藥上可以接受的包裝 |
WO2006084389A1 (fr) * | 2005-02-11 | 2006-08-17 | Cilag Ltd. | Procede pour epurer des composes de noroxymorphone |
JP5314894B2 (ja) | 2005-03-04 | 2013-10-16 | ユーロ−セルティーク エス.エイ. | オピオイド組成物中のアルファ,ベータ不飽和ケトンの減少方法 |
WO2007062184A2 (fr) | 2005-11-22 | 2007-05-31 | Controlled Chemicals, Inc. | Procédés destinés à réduire les taux d'accepteurs de michael contaminants dans l'oxycodone et d'autres compositions |
WO2007103105A2 (fr) * | 2006-03-02 | 2007-09-13 | Mallinckrodt Inc. | Procédés de préparation de produits à base de morphinan-6-one avec de faibles niveaux de composés de cétones alpha, bêta-insaturées |
GB0624880D0 (en) * | 2006-12-14 | 2007-01-24 | Johnson Matthey Plc | Improved method for making analgesics |
EA028092B1 (ru) * | 2012-07-16 | 2017-10-31 | Родс Текнолоджис | Способ усовершенствованного синтеза опиоидов |
GB201313915D0 (en) | 2013-08-02 | 2013-09-18 | Johnson Matthey Plc | Process |
-
2015
- 2015-07-08 CA CA2954600A patent/CA2954600A1/fr not_active Abandoned
- 2015-07-08 MA MA040332A patent/MA40332A/fr unknown
- 2015-07-08 WO PCT/IB2015/055171 patent/WO2016005923A1/fr active Application Filing
- 2015-07-08 US US15/324,528 patent/US20170342084A1/en not_active Abandoned
- 2015-07-08 EP EP15744360.7A patent/EP3166948A1/fr not_active Withdrawn
-
2019
- 2019-09-20 US US16/578,278 patent/US20200223859A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
WO2016005923A1 (fr) | 2016-01-14 |
EP3166948A1 (fr) | 2017-05-17 |
US20170342084A1 (en) | 2017-11-30 |
CA2954600A1 (fr) | 2016-01-14 |
US20200223859A1 (en) | 2020-07-16 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CL2016002310A1 (es) | Nuevos compuestos bicíclicos. | |
ZA201608077B (en) | Combination, composition, and method of administering the combination or composition to animals | |
BR112017004612A2 (pt) | compostos, composição farmacêutica, usos de um composto, e kit | |
BR112016018521A2 (pt) | composição, e, kit. | |
BR112016025246A2 (pt) | composição de preservativo de madeira | |
BR112016015706A2 (pt) | composto, uso do mesmo e composição farmacêutica | |
EP3139920A4 (fr) | Composés anti-viraux, compositions pharmaceutiques et méthodes d'utilisation de ceux-ci | |
BR112016023341A2 (pt) | composição desinfetante de ação rápida | |
BR112016028543A2 (pt) | composições orais contendo íons de metal. | |
BR112017005255A2 (pt) | composições não gordurosas de cuidado pessoal. | |
IL249646A0 (en) | Platinum compounds, preparations, and their uses | |
EP3135650A4 (fr) | Adjuvant pour composition hydraulique | |
EP3132795A4 (fr) | Composition pour la prévention ou le traitement de maladies hépatiques graisseuses | |
IL248783A0 (en) | Fluorescence quenching compounds, preparations containing them and their uses | |
DK3230481T3 (da) | Ferritisk legering | |
DK3241551T3 (da) | Farmaceutisk sammensætning til behandling af kræft, indeholdende lactatmetalsalt | |
EP3169405A4 (fr) | Méthodes, composés et compositions pour le traitement de maladies musculo-squelettiques | |
SI3220893T1 (sl) | Sestavek na osnovi COQ10 | |
BR112016015712A2 (pt) | método de tratamento de doenças hepáticas. | |
MA40332A (fr) | Réduction des niveaux de cétone alpha, beta-insaturée dans des compositions de dérivés de morphinane | |
BR112016030507A2 (pt) | Compostos relacionados à vitamina d, composição farmacêutica, e kit | |
DK3169322T3 (da) | Diætetisk sammensætning med antidyslipidemisk aktivitet | |
MA41641A (fr) | Dérivés de tétrahydropyranylbenzamide | |
DK3199160T3 (da) | Vandig sammensætning | |
BR112017013928A2 (pt) | composição alimentar e método de uso. |